Christopher C. Chapman Jr serves as Executive at MyMD Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Christopher C. Chapman Jr has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 16, 2021 involved receiving (via award) 96,475 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Apr 16, 2021 | MYMD | $0 | Award | 96,475 | $N/A | Discretionary |
Christopher C. Chapman Jr currently holds 96,475 shares of MyMD Pharmaceuticals, Inc. (MYMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher C. Chapman Jr has been a net neutral trader of MYMD stock. They have purchased $0 and sold $0 worth of shares.
Christopher C. Chapman Jr's most recent insider trade was on Apr 16, 2021, when they sold 96,475 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted